SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

Clinical features, plasma neurotransmitter levels and plasma neurohormone levels in sleep disorders among patients with early-stage Parkinson’s disease

· 2024-09-02

DOI: 10.21203/rs.3.rs-4813635/v1

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Background: Sleep disorders occur frequently in patients with Parkinson’s disease (PD). Neurotransmitters and neurosteroids are known to be involved in various neurophysiological processes, including sleep development. Objective:We aimed to assess the association between peripheral neurotransmitter and neurosteroid levels and various sleep disorders in early-stage PD. Methods: 59 patients with early-stage PD and 30 healthy controls were enrolled. Demographic and clinical data were collected and sleep conditions were comprehensively assessed with clinical questionnaires and polysomnography. Blood samples were obtained at 1:00 AM and 9:00 AM in all participants. The concentrations of plasma neurotransmitters and neurohormones were detected using high-performance liquid chromatography tandem mass spectrometry. Results: Sleep disorders were common non-motor symptoms (81.4%) and coexisted in approximately half of the patients. Dysautonomia was significantly associated with the presence of multiple sleep disorders. RBD was associated with dysautonomia and was negatively correlated with plasma melatonin concentration at 1:00 AM (r = −0.40, p = 0.002) in early-stage PD patients. The RLS group had higher PSQI score, and RLS was negatively associated with the levels of 5-hydroxytryptamine (r = −0.40, p = 0.002) at 1:00 AM and glutamine (r = −0.39, p = 0.002) at 9:00 AM. SDB was associated with cognitive impairment, higher body mass index, and lower plasma acetylcholine concentrations at 1:00 AM. Conclusion: Combined sleep disturbances were frequent in early-stage PD. Dysautonomia was closely related to various sleep disorders, including RBD, EDS, and insomnia. Changes in peripheral neurotransmitter and neurohormone levels may be involved in the development of sleep disorders.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.